Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-028279

Audentes Therapeutics, Inc. · BOLD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Apr 24, 2017
Accepted (ET)
Apr 26, 2017 · 8:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628738

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Apr 24, 2017P4,331$14.50A64,431IBy 5AM Co-Investors III, L.P.
Common StockF1Apr 24, 2017P168,082$14.50A2,500,113IBy 5AM Ventures III, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses